3. Vironen JH, Kairaluoma M, Aalto AM, Kellokumpu IH. Impact of functional results on quality of life after rectal cancer surgery. Dis Colon Rectum 2006;49:568–78.
4. Dulskas A, Miliauskas P, Tikuisis R, Escalante R, Samalavicius NE. The functional results of radical rectal cancer surgery: review of the literature. Acta Chir Belg 2016;116:1–10.
5. Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 2010;24:1205–10.
6. Veltcamp Helbach M, Koedam TW, Knol JJ, Velthuis S, Bonjer HJ, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 2019;33:79–87.
7. Larsen SG, Pfeffer F, Kørner H, Norwegian Colorectal Cancer Group. Norwegian moratorium on transanal total mesorectal excision. Br J Surg 2019;106:1120–1.
8. Perdawood SK, Thinggaard BS, Bjoern MX. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries. Surg Endosc 2018;32:2312–21.
10. Roodbeen SX, Spinelli A, Bemelman WA, Di Candido F, Cardepont M, Denost Q, et al. Local recurrence after transanal total mesorectal excision for rectal cancer: a multicenter cohort study. Ann Surg 2021;274:359–66.
11. Rasmussen OO, Petersen IK, Christiansen J. Anorectal function following low anterior resection. Colorectal Dis 2003;5:258–61.
12. Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010;76:1005–11.
13. Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life after transanal endoscopic microsurgery. Br J Surg 2011;98:1635–43.
16. Pucciani F. A review on functional results of sphincter-saving surgery for rectal cancer: the anterior resection syndrome. Updates Surg 2013;65:257–63.
17. Bloemen JG, Visschers RG, Truin W, Beets GL, Konsten JL. Long-term quality of life in patients with rectal cancer: association with severe postoperative complications and presence of a stoma. Dis Colon Rectum 2009;52:1251–8.
18. Peeters KC, Tollenaar RA, Marijnen CA, Klein Kranenbarg E, Steup WH, Wiggers T, et al. Risk factors for anastomotic failure after total mesorectal excision of rectal cancer. Br J Surg 2005;92:211–6.
19. Veltcamp Helbach M, van Oostendorp SE, Koedam TW, Knol JJ, Stockmann HB, Oosterling SJ, et al. Structured training pathway and proctoring; multicenter results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands. Surg Endosc 2020;34:192–201.
20. Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 2010;147:339–51.
21. van Heinsbergen M, Van der Heijden JA, Stassen LP, Melenhorst J, de Witte E, Belgers EH, et al. The low anterior resection syndrome in a reference population: prevalence and predictive factors in the Netherlands. Colorectal Dis 2020;22:46–52.
22. Deutekom M, Terra MP, Dobben AC, Dijkgraaf MG, Felt-Bersma RJ, Stoker J, et al. Selecting an outcome measure for evaluating treatment in fecal incontinence. Dis Colon Rectum 2005;48:2294–301.
23. Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrantonis C, Thorson AG, et al. Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000;43:9–16.
24. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
25. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
26. Dou R, Sun W, Luo S, Hou Y, Zhang C, Kang L. Comparison of postoperative bowel function between patients undergoing transanal and laparoscopic total mesorectal excision. Zhonghua Wei Chang Wai Ke Za Zhi 2019;22:246–54.
27. Bjoern MX, Nielsen S, Perdawood SK. Quality of life after surgery for rectal cancer: a comparison of functional outcomes after transanal and laparoscopic approaches. J Gastrointest Surg 2019;23:1623–30.
29. Reali C, Keller DS, Penna M, Hompes R. Low anterior resection syndrome: are we getting to the bottom of the problem with TaTME? Colorectal Dis 2018;20(Suppl 4): 41.
30. Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, Rullier E. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Surg Endosc 2016;30:4924–33.
31. Turrado-Rodriguez V, Torroella AT, De Lacy Oliver F, Guarner Piquet P, Otero-Pineiro A, Martin-Perez B, et al. Functional outcomes after tatme: retrospective analysis of quality of life and pelvic function. Dis Colon Rectum 2018;61:e222.
32. de’Angelis N, Portigliotti L, Azoulay D, Brunetti F. Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of the literature. Langenbecks Arch Surg 2015;400:945–59.
33. Leão P, Santos C, Goulart A, Caetano AC, Sousa M, Hogemann G, et al. TaTME: analysis of the evacuatory outcomes and EUS anal sphincter. Minim Invasive Ther Allied Technol 2019;28:332–7.
34. ‘t Hoen LA, Utomo E, Schouten WR, Blok BF, Korfage IJ. The fecal incontinence quality of life scale (FIQL) and fecal incontinence severity index (FISI): validation of the Dutch versions. Neurourol Urodyn 2017;36:710–5.
35. Keller DS, Reali C, Spinelli A, Penna M, Di Candido F, Cunningham C, et al. Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision. Br J Surg 2019;106:364–6.
36. Mora L, Zarate A, Serra-Aracil X, Pallisera A, Serra S, NavarroSoto S. Functional impairment and quality of life after rectal cancer surgery. Cir Cir 2018;86:140–7.
37. van der Heijden JA, van Heinsbergen M, Thomas G, Caers F, Slooter GD, Maaskant-Braat AJ. Implementation of a postoperative screening and treatment guidance for the low anterior resection syndrome: preliminary results. Dis Colon Rectum 2019;62:1033–42.
38. Koedam TW, Veltcamp Helbach M, van de Ven PM, Kruyt PM, van Heek NT, Bonjer HJ, et al. Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve. Tech Coloproctol 2018;22:279–87.
39. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 2019;269:589–95.
40. Stevenson AR, Solomon MJ, Brown CS, Lumley JW, Hewett P, Clouston AD, et al. Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the australasian laparoscopic cancer of the rectum randomized clinical trial. Ann Surg 2019;269:596–602.
41. Lee L, Kelly J, Nassif GJ, deBeche-Adams TC, Albert MR, Monson JRT. Defining the learning curve for transanal total mesorectal excision for rectal adenocarcinoma. Surg Endosc 2020;34:1534–42.